Invitation to bid for the selection of First Line anti-TB drugs
22 October 2014 - Geneva - On behalf of the Global Drug Facility (GDF) of the Stop TB Partnership, IDA Foundation, the GDF contracted procurement agent invites all eligible suppliers to submit a bid for the First Line anti-TB drugs described in this Invitation to Bid (ITB).
This Invitation to Bid is open to bidders whose products have been deemed eligible for inclusion in the tender in compliance with the GDF's Quality Assurance policy and procedures (published at www.stoptb.org/gdf). A bid submitted for a product for which the bidder has not received regulatory approval status in accordance with the GDF Quality Assurance policy and procedures shall not be considered in the ITB evaluation.
All bids are subject to the Instructions to Bidders and such other provisions, specifications and instructions contained in this dossier. The ITB comprises the following in order of precedence:
- ITB DOC, including SECTIONS 1-9
- Annex A: Bid response form (Excel spread sheet)
- Annex B: Technical Specifications / Product list
- Annex C: Response form for Registration (in High Burden Countries)
- Annex D: IDA Model Long-term Agreement (LTA)
- Annex E: IDA General Terms and Conditions
- Annex F: IDA Code of Conduct
- Annex G: Disclosure Letter for Access to information
- Annex H: Indicative non-binding Forecasts for 2015
Failure to adhere to the requirements of this ITB may be grounds for disqualification of the Bidder and/or rejection of the bid.
The bid must be submitted electronically and no later than 16.00 hours Indian Standard Time (IST) on 14th November 2014 to bids@idafoundation.org. Faxed or courier proposals are not acceptable.
Source: Stop TB Partnership
